Raporty

6/2015 Conclusion of annexes to loan agreements with Bank Millennium S.A.

The Management Board of Centrum Medyczne ENEL-MED S.A. would like to inform you that on 22 April 2015 the Company concluded with Bank Millennium S.A. (“Bank”) the annexes to agreements, extending the agreements concluded previously for the multi-product line and the corporate mortgage loan.

In accordance with the annex to the agreement for a multi-product line, the Bank granted the Company a global limit of PLN 15,000,000.00 for the period from 11 August 2014 to 24 April 2016. The loan will be used to finance current activities of the Issuer, while the interest rate is based on variable interest rate amounting to WIBOR 1M plus the bank margin. A sublimit for bank guarantees of PLN 9,000,000.00 is set within the global limit granted. Remaining funds are to be used to finance current activities of the Company.

The loans is secured with a blank promissory note, mortgage up to PLN 28,900,000.00 on real estate being the property of the Company, located in Warsaw, at ul. Gilarska 86C, together with the assignment of rights to the insurance contract, as well as unconfirmed assignment of receivables from contracts concluded with the National Health Fund.

In accordance with the annex to the corporate mortgage loan, the Bank granted the Company a loan of PLN 10,000,000.00 for the period from 22 April 2015 to 24 May 2019. The loan will be used to finance current activities of the Issuer, while the interest rate of the loan is based on variable interest rate amounting to WIBOR 1M plus the bank margin.

The loans is secured with the mortgage up to PLN 17,680,000.00 on the aforementioned real estate being the property of the Company, and unconfirmed assignment of receivables from contracts concluded with the National Health Fund.

Provisions of annexes do not differ from market terms.

The total value of agreements concluded is PLN 25,000,000.00.

Agreements were considered significant, since in total they exceed 10% of equity of the Issuer, and additionally, one of the annexes concluded exceeds 10% of the Company’s equity.